Literature DB >> 18154485

Cancer chemoprevention through dietary antioxidants: progress and promise.

Naghma Khan1, Farrukh Afaq, Hasan Mukhtar.   

Abstract

It is estimated that nearly one-third of all cancer deaths in the United States could be prevented through appropriate dietary modification. Various dietary antioxidants have shown considerable promise as effective agents for cancer prevention by reducing oxidative stress which has been implicated in the development of many diseases, including cancer. Therefore, for reducing the incidence of cancer, modifications in dietary habits, especially by increasing consumption of fruits and vegetables rich in antioxidants, are increasingly advocated. Accumulating research evidence suggests that many dietary factors may be used alone or in combination with traditional chemotherapeutic agents to prevent the occurrence of cancer, their metastatic spread, or even to treat cancer. The reduced cancer risk and lack of toxicity associated with high intake of fruits and vegetables suggest that specific concentrations of antioxidant agents from these dietary sources may produce cancer chemopreventive effects without causing significant levels of toxicity. This review presents an extensive analysis of the key findings from studies on the effects of dietary antioxidants such as tea polyphenols, curcumin, genistein, resveratrol, lycopene, pomegranate, and lupeol against cancers of the skin, prostate, breast, lung, and liver. This research is also leading to the identification of novel cancer drug targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154485     DOI: 10.1089/ars.2007.1740

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  153 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Nanochemoprevention: sustained release of bioactive food components for cancer prevention.

Authors:  Imtiaz A Siddiqui; Vaqar M Adhami; Nihal Ahmad; Hasan Mukhtar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

3.  Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45α-dependent manner.

Authors:  Srirupa Roy; Gagan Deep; Chapla Agarwal; Rajesh Agarwal
Journal:  Carcinogenesis       Date:  2011-12-12       Impact factor: 4.944

4.  p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

Authors:  Srirupa Roy; Mallikarjuna Gu; Kumaraguruparan Ramasamy; Rana P Singh; Chapla Agarwal; Sunitha Siriwardana; Robert A Sclafani; Rajesh Agarwal
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 5.  Future directions in the prevention of prostate cancer.

Authors:  Ian M Thompson; April B Cabang; Michael J Wargovich
Journal:  Nat Rev Clin Oncol       Date:  2013-11-26       Impact factor: 66.675

6.  Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.

Authors:  Tao Niu; Diane L Smith; Zhen Yang; Song Gao; Taijun Yin; Zhi-Hong Jiang; Ming You; Richard A Gibbs; Joseph F Petrosino; Ming Hu
Journal:  Pharm Res       Date:  2012-12-20       Impact factor: 4.200

7.  Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators.

Authors:  Samiha Mateen; Alpna Tyagi; Chapla Agarwal; Rana P Singh; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2010-03       Impact factor: 4.784

Review 8.  Lifestyle as risk factor for cancer: Evidence from human studies.

Authors:  Naghma Khan; Farrukh Afaq; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2010-01-18       Impact factor: 8.679

9.  Gastroprotective effect of lupeol on ethanol-induced gastric damage and the underlying mechanism.

Authors:  Silvéria Regina de S Lira; Vietla Satyanarayana Rao; Ana Carla S Carvalho; Marjorie M Guedes; Talita C de Morais; Antonia L de Souza; Maria Teresa S Trevisan; Alana F Lima; Mariana H Chaves; Flávia A Santos
Journal:  Inflammopharmacology       Date:  2009-07-16       Impact factor: 4.473

Review 10.  Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.

Authors:  Vaqar Mustafa Adhami; Deeba Nadeem Syed; Naghma Khan; Hasan Mukhtar
Journal:  Biochem Pharmacol       Date:  2012-07-25       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.